These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 10986525)

  • 1. Agreement between muscle movement and peripheral nerve stimulation in critically ill pediatric patients receiving neuromuscular blocking agents.
    Peña O; Prestjohn S; Guzzetta CE
    Heart Lung; 2000; 29(5):309-18. PubMed ID: 10986525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective pharmacoeconomic evaluation of dosing vecuronium by peripheral nerve stimulation versus standard clinical assessment in critically ill patients.
    Zarowitz BJ; Rudis MI; Lai K; Petitta A; Lulek M
    Pharmacotherapy; 1997; 17(2):327-32. PubMed ID: 9085324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised controlled trial comparing cisatracurium and vecuronium infusions in a paediatric intensive care unit.
    Burmester M; Mok Q
    Intensive Care Med; 2005 May; 31(5):686-92. PubMed ID: 15815895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased cis-atracurium requirements during prolonged administration to a child.
    Tobias JD
    Can J Anaesth; 1997 Jan; 44(1):82-4. PubMed ID: 8988829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of implementation of neuromuscular blockade monitoring standards in a surgical intensive care unit.
    Frankel H; Jeng J; Tilly E; St Andre A; Champion H
    Am Surg; 1996 Jun; 62(6):503-6. PubMed ID: 8651538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of two depths of prolonged neuromuscular blockade induced by cisatracurium in mechanically ventilated critically ill patients.
    Lagneau F; D'honneur G; Plaud B; Mantz J; Gillart T; Duvaldestin P; Marty J; Clyti N; Pourriat JL
    Intensive Care Med; 2002 Dec; 28(12):1735-41. PubMed ID: 12447516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Practice Guidelines for Sustained Neuromuscular Blockade in the Adult Critically Ill Patient.
    Murray MJ; DeBlock H; Erstad B; Gray A; Jacobi J; Jordan C; McGee W; McManus C; Meade M; Nix S; Patterson A; Sands MK; Pino R; Tescher A; Arbour R; Rochwerg B; Murray CF; Mehta S
    Crit Care Med; 2016 Nov; 44(11):2079-2103. PubMed ID: 27755068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, randomized, controlled evaluation of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents in critically ill patients.
    Rudis MI; Sikora CA; Angus E; Peterson E; Popovich J; Hyzy R; Zarowitz BJ
    Crit Care Med; 1997 Apr; 25(4):575-83. PubMed ID: 9142020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral electrical stimulation: titrating neuromuscular blocking agent levels.
    Hill L
    Dimens Crit Care Nurs; 1995; 14(6):305-14. PubMed ID: 8631213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuromuscular monitoring].
    Nitahara K; Sugi Y; Higa K
    Masui; 2008 Jul; 57(7):824-30. PubMed ID: 18649636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of peripheral nerve stimulators to monitor patients with neuromuscular blockade in the ICU.
    Kleinpell R; Bedrosian C; McCormick L; Kremer M; Bujalski L; Bronsted R
    Am J Crit Care; 1996 Nov; 5(6):449-54. PubMed ID: 8922161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A national survey of critical care nurses' practices related to administration of neuromuscular blocking agents.
    Foster JG; Kish SK; Keenan CH
    Am J Crit Care; 2001 May; 10(3):139-45. PubMed ID: 11340735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Train-of-four: to use or not to use.
    Tschida SJ; Hoey LL; Mather D; Vance-Bryan K
    Pharmacotherapy; 1995; 15(4):546-50. PubMed ID: 7479212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients.
    Prielipp RC; Coursin DB; Scuderi PE; Bowton DL; Ford SR; Cardenas VJ; Vender J; Howard D; Casale EJ; Murray MJ
    Anesth Analg; 1995 Jul; 81(1):3-12. PubMed ID: 7598277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of the neuromuscular blockade levels on amplitudes of posttetanic motor-evoked potentials and movement in response to transcranial stimulation in patients receiving propofol and fentanyl anesthesia.
    Yamamoto Y; Kawaguchi M; Hayashi H; Horiuchi T; Inoue S; Nakase H; Sakaki T; Furuya H
    Anesth Analg; 2008 Mar; 106(3):930-4, table of contents. PubMed ID: 18292442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of intermediate acting muscle relaxants by infusion: the future.
    Mirakhur RK; McCourt KC; Kumar N
    Acta Anaesthesiol Belg; 1997; 48(1):29-34. PubMed ID: 9099306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inconsistency with train-of-four monitoring in a critically ill paralyzed patient.
    Tschida SJ; Hoey LL; Vance-Bryan K
    Pharmacotherapy; 1995; 15(4):540-5. PubMed ID: 7479211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring neuromuscular blockade in the adult ICU.
    Ford EV
    Am J Crit Care; 1995 Mar; 4(2):122-30; quiz 131-2. PubMed ID: 7749444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-resistance to both atracurium- and vecuronium-induced neuromuscular blockade in a critically ill patient.
    Fish DN; Singletary TJ
    Pharmacotherapy; 1997; 17(6):1322-7. PubMed ID: 9399619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bispectral index monitoring during the administration of neuromuscular blocking agents in the pediatric intensive care unit patient.
    Tobias JD; Grindstaff R
    J Intensive Care Med; 2005; 20(4):233-7. PubMed ID: 16061906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.